匹立尼酸

{{Drugbox
| IUPAC_name = 2-({4-chloro-6-[(2,3-dimethylphenyl)amino]pyrimidin-2-yl}sulfanyl)acetic acid
| image = Pirinixic acid.svg
| alt =

| tradename =
| pregnancy_AU =
| pregnancy_US =
| pregnancy_category =
| legal_AU =
| legal_CA =
| legal_UK =
| legal_US =
| legal_status =
| routes_of_administration =

| bioavailability =
| protein_bound =
| metabolism =
| elimination_half-life =
| excretion =

| IUPHAR_ligand = 2666
| CAS_number = 50892-23-4
| ATCvet =
| ATC_prefix =
| ATC_suffix =
| PubChem = 5694
| DrugBank =
| UNII_Ref =
| UNII = 86C4MRT55A
| ChEMBL = 295416
| ChemSpiderID = 5492

| C=14 | H=14 | Cl=1 | N=3 | O=2 | S=1
| smiles = Cc1cccc(c1C)Nc2cc(nc(n2)SCC(=O)O)Cl
| StdInChI = 1S/C14H14ClN3O2S/c1-8-4-3-5-10(9(8)2)16-12-6-11(15)17-14(18-12)21-7-13(19)20/h3-6H,7H2,1-2H3,(H,19,20)(H,16,17,18)
| StdInChIKey = SZRPDCCEHVWOJX-UHFFFAOYSA-N
}}

匹立尼酸是一种有机化合物，化学式为C14H14ClN3O2S，它是（PPARα）激动剂，目前处于实验研究中，用于预防由于心肌细胞内脂质积累而导致的严重心功能障碍、心肌病和心力衰竭。它在1974年被发现。

参考文献